A proof of concept study to evaluate the effects of intranasal salmeterol and fluticasone given alone and in combination in allergic rhinitis

Trial Profile

A proof of concept study to evaluate the effects of intranasal salmeterol and fluticasone given alone and in combination in allergic rhinitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Fluticasone propionate (Primary) ; Salmeterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
  • Indications Allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jun 2012 Actual end date (1 Oct 2010) added as reported by ClinicalTrials.gov.
    • 10 Jan 2012 Status changed from active, no longer recruiting to completed.
    • 05 Jul 2011 Additional lead trial centres and investigators identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top